UK on OTC ads
This article was originally published in The Tan Sheet
Guidelines for advertisements promoting OTCs for previously restricted indications are expected by year-end, UK's Medicines & Healthcare Products Regulatory Agency announces Aug. 11. Under the new guidelines, aspirin may be promoted for secondary prevention of heart attacks, while calcium and vitamin D products may be touted to prevent osteoporosis. Agency proposed amending the 1994 regulations in a November 2002 consultation letter (1"The Tan Sheet" Nov. 11, 2002, p. 17). Forty-one comments were received, of which 13 opposed removal of the restrictions and 31 supported the initiative...
You may also be interested in...
Promoting aspirin 75 mg to consumers for secondary prevention of heart attack or stroke would be permitted in the UK under a proposal issued for consultation by the country's Medicines Control Agency Nov. 4
CBER Director Peter Marks said the agency could streamline development by allowing sponsors to depend on an already-approved manufacturing platform and reviewing any modifications that are proposed.
Only 12 US jurisdictions currently have sound COVID-19 virus assays from the Centers for Disease Control and Prevention to test suspected virus cases, CDC director Robert Redfield told a House panel looking at virus preparedness on Wednesday – but a better batch is coming, he said. Other questions raised at the congressional hearing was how long an infected person stays infected, whether COVID-19 can be picked up from inanimate surfaces, and related queries.